Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). [See USP Controlled Room Temperature.]
MARCAINE SPINAL solution may be autoclaved once at 15 pound pressure, 121°C (250°F) for 15 minutes. This product is clear and colorless. Do not use the solution if it is discolored or contains particulate matter.
Single-dose ampules of 2 mL MARCAINE SPINAL (bupivacaine hydrochloride in dextrose injection) (15 mg bupivacaine hydrochloride with 165 mg dextrose) are supplied as follows:
| Unit of Sale | Concentration |
|---|---|
| NDC 0409-1761-02 Carton of 10 Uni-Amp™ single-dose ampules | 15 mg/2 mL (7.5 mg/mL) |
| NDC 0409-1761-10 Carton of 2 clamcells each containing 5 single-dose ampules | 15 mg/2 mL (7.5 mg/mL) |
| NDC 0409-1761-62 Case of 800 single-dose ampules | 15 mg/2 mL (7.5 mg/mL) |
Discard the unused portion.
Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). [See USP Controlled Room Temperature.]
MARCAINE SPINAL solution may be autoclaved once at 15 pound pressure, 121°C (250°F) for 15 minutes. This product is clear and colorless. Do not use the solution if it is discolored or contains particulate matter.
Single-dose ampules of 2 mL MARCAINE SPINAL (bupivacaine hydrochloride in dextrose injection) (15 mg bupivacaine hydrochloride with 165 mg dextrose) are supplied as follows:
| Unit of Sale | Concentration |
|---|---|
| NDC 0409-1761-02 Carton of 10 Uni-Amp™ single-dose ampules | 15 mg/2 mL (7.5 mg/mL) |
| NDC 0409-1761-10 Carton of 2 clamcells each containing 5 single-dose ampules | 15 mg/2 mL (7.5 mg/mL) |
| NDC 0409-1761-62 Case of 800 single-dose ampules | 15 mg/2 mL (7.5 mg/mL) |
Discard the unused portion.
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.